← Back to Analyst Consensus 
TOVX Buy
Theriva Biologics, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 31, 2026 | Maxim Group | upgrade | Hold → Buy | — | 42% |
| May 8, 2025 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Nov 13, 2024 | Maxim Group | maintain | Buy → Buy | $6 | 42% |
Price Target Trend
Apr 17, 2026 Oct 25, 2026
EPS Estimates
0y —
+1q —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days